Molecular Oncology and Immunotherapy,
Department of General,
Visceral,
Vascular and Transplantation Surgery,
Molecular Oncology and Immunotherapy, Department of General, Visceral, Vascular and Transplantation Surgery
Michael Linnebacher has not added Biography.
If you are Michael Linnebacher and would like to personalize this page please email our Author Liaison for assistance.
Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
Neoplasia (New York, N.Y.) 04, 2017 | Pubmed ID: 28284059
An in vitro system for the determination of individualized immunosuppression.
Transplantation proceedings May, 2008 | Pubmed ID: 18555078
Lysates of S. pyogenes serotype M49 induce pancreatic tumor growth delay by specific and unspecific antitumor immune responses.
Journal of immunotherapy (Hagerstown, Md. : 1997) Oct, 2008 | Pubmed ID: 18779749
Identification of an MSI-H tumor-specific cytotoxic T cell epitope generated by the (-1) frame of U79260(FTO).
Journal of biomedicine & biotechnology , 2010 | Pubmed ID: 20339516
Cryopreservation of human colorectal carcinomas prior to xenografting.
BMC cancer Jul, 2010 | Pubmed ID: 20615215
Bacterial immunotherapy of gastrointestinal tumors.
Langenbeck's archives of surgery Apr, 2012 | Pubmed ID: 22189906
Tumor-infiltrating B cells come into vogue.
World journal of gastroenterology Jan, 2013 | Pubmed ID: 23326156
Frameshift-derived neoantigens constitute immunotherapeutic targets for patients with microsatellite-instable haematological malignancies: frameshift peptides for treating MSI+ blood cancers.
European journal of cancer (Oxford, England : 1990) Jul, 2013 | Pubmed ID: 23561850
Optimizing the process of nucleofection for professional antigen presenting cells.
BMC research notes Sep, 2015 | Pubmed ID: 26404473
Generation of Xenotransplants from Human Cancer Biopsies to Assess Anti-cancer Activities of HDACi.
Methods in molecular biology (Clifton, N.J.) , 2017 | Pubmed ID: 27761824
Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies.
Journal of translational medicine 02, 2017 | Pubmed ID: 28183348
Establishment, functional and genetic characterization of a colon derived large cell neuroendocrine carcinoma cell line.
World journal of gastroenterology Sep, 2018 | Pubmed ID: 30197480
Establishment, functional and genetic characterization of three novel patient-derived rectal cancer cell lines.
World journal of gastroenterology Nov, 2018 | Pubmed ID: 30487698
Colorectal cancer vaccines: Tumor-associated antigens neoantigens.
World journal of gastroenterology Dec, 2018 | Pubmed ID: 30622371
Human Colorectal Carcinoma Infiltrating B Lymphocytes Are Active Secretors of the Immunoglobulin Isotypes A, G, and M.
Cancers Jun, 2019 | Pubmed ID: 31167511
NSG mice as hosts for oncological precision medicine.
Laboratory investigation; a journal of technical methods and pathology 01, 2020 | Pubmed ID: 31409886
Integrated Biobanking and Tumor Model Establishment of Human Colorectal Carcinoma Provides Excellent Tools for Preclinical Research.
Cancers Oct, 2019 | Pubmed ID: 31601052
Connecting Cancer Pathways to Tumor Engines: A Stratification Tool for Colorectal Cancer Combining Human In Vitro Tissue Models with Boolean In Silico Models.
Cancers Dec, 2019 | Pubmed ID: 31861874
Mouse models of colorectal cancer: Past, present and future perspectives.
World journal of gastroenterology Apr, 2020 | Pubmed ID: 32308343
Patient-individual cancer cell lines and tissue analysis delivers no evidence of sequences from DNA viruses in colorectal cancer cells.
BMC gastroenterology Aug, 2020 | Pubmed ID: 32762707
Pharmaceutical immunoglobulin G impairs anti-carcinoma activity of oxaliplatin in colon cancer cells.
British journal of cancer Feb, 2021 | Pubmed ID: 33558709
CIITA-Transduced Glioblastoma Cells Uncover a Rich Repertoire of Clinically Relevant Tumor-Associated HLA-II Antigens.
Molecular & cellular proteomics : MCP Jan, 2021 | Pubmed ID: 33592498
Florian Bürtin1,
Stephanie Matschos2,
Friedrich Prall3,
Christina S. Mullins2,
Mathias Krohn2,
Michael Linnebacher2
1Department of General, Visceral, Vascular and Transplantation Surgery, University Medical Center Rostock, University of Rostock,
2Molecular Oncology and Immunotherapy, Department of General, Visceral, Vascular and Transplantation Surgery, University Medical Center Rostock,
3Institute of Pathology, University Medical Center Rostock
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유